government policy
-
A toolkit for new advocates: What I learned from the Long COVID Moonshot campaign
While the multi-billion dollar Long COVID Moonshot bill is currently stalled, advocates learned many important lessons that the community must carry into future efforts.
-
RECOVER’s first round of clinical trials are failing. Will the next phase be better?
The NIH studies found that Paxlovid, ivabradine, and computer games did not significantly improve symptoms of Long COVID. Further analysis that may help future research research has not yet been released.
-
What is the federal government currently doing about Long COVID?
In this episode of Still Here, hosts Betsy Ladyzhets and Miles Griffis talk about the latest updates from the US Department of Health and Human Services and their efforts on Long COVID, as well as the criticisms they face from members of the community. Subscribe to Still Here wherever you get your podcasts, and leave…
-
“Not a whole lot of substance”: HHS posts Long COVID website, six months after making big promises
New website receives mixed reviews from Long COVID advocates and researchers; some do not expect to see any meaningful support from the Trump administration.
-
Austin recognizes Long COVID Awareness Day, events happen around the world
Around the world, people with Long COVID recognized International Long COVID Awareness Day with events, demonstrations, and buildings lit up in teal. Austin, Texas, is the latest city to recognize the day, through a proclamation from the Austin city council — a major step in the state.
-
Maryland considers Long COVID innovation bill
Maryland may soon become the first U.S. state to directly support Long COVID research and development. The state’s government is considering a bill that would establish a grant and loan program dedicated to the disease, potentially funding scientists and start-ups based in Maryland.
-
HHS hosts event and announces new initiatives for Lyme disease, but advocates are skeptical about follow-through
The Lyme disease roundtable followed a similar event on Long COVID, which still hasn’t led to action on the disease
-
Doctors who refuse to engage with administrative work are abandoning their poorest and sickest patients
Having a Long COVID or ME doctor who is willing and available to engage with survival admin makes the difference between being able to access necessities and going without, and can be the only lifeline against neglect.
-
Research updates, December 9
A new study in the International Journal of Infectious Diseases examines how COVID-19 impacts the immune system.
-
The future of Medicaid is “really scary” for people with Long COVID
The deep cuts to Medicaid funding in the Trump administration’s spending bill of almost $1 trillion — as well as new requirements making Medicaid more difficult to obtain and maintain — will hit disadvantaged groups hard. For many with Long COVID, the cuts put their lives and well-being at risk.
Follow Us
get the latest long covid news
Trending
Recent ARTICLES
-
International ME/CFS Conference roundup: Setbacks and new hopes for therapeutic research
-
National COVID-19 trends, May 26
-
Research updates, May 26
-
Mold exposure can trigger and worsen chronic illness. Climate change will increase the risk.
-
A toolkit for new advocates: What I learned from the Long COVID Moonshot campaign
Tags
advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health research update science Trump administration updates and events vaccines wastewater surveillance